These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24333618)

  • 41. Anticoagulants, renal failure and atrial fibrillation.
    Genovesi S; Santoro A
    Expert Opin Drug Saf; 2013 Jan; 12(1):1-3. PubMed ID: 23163428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. WATCHMAN matches warfarin.
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):456. PubMed ID: 19419252
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical practice. Care of patients receiving long-term anticoagulant therapy.
    Schulman S
    N Engl J Med; 2003 Aug; 349(7):675-83. PubMed ID: 12917305
    [No Abstract]   [Full Text] [Related]  

  • 44. Updated guidelines on outpatient anticoagulation.
    Wigle P; Hein B; Bloomfield HE; Tubb M; Doherty M
    Am Fam Physician; 2013 Apr; 87(8):556-66. PubMed ID: 23668445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Rivaroxaban versus warfarin: results of the ROCKET study].
    Lipták J
    Ideggyogy Sz; 2012 Sep; 65(9-10):349-51. PubMed ID: 23126221
    [No Abstract]   [Full Text] [Related]  

  • 46. Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.
    Yates SW
    Hosp Pract (1995); 2011 Oct; 39(4):7-16. PubMed ID: 22056819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bleeding risk on warfarin among elderly patients with atrial fibrillation.
    Cowan A; Hylek EM
    J Am Coll Cardiol; 2010 Mar; 55(9):932; author reply 932-3. PubMed ID: 20185052
    [No Abstract]   [Full Text] [Related]  

  • 48. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
    Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
    Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.
    Lane D; Lip GY
    Age Ageing; 2005 Jan; 34(1):1-3. PubMed ID: 15591476
    [No Abstract]   [Full Text] [Related]  

  • 50. Should patients with advanced chronic kidney disease and atrial fibrillation receive chronic anticoagulation?
    Clase CM; Holden RM; Sood MM; Rigatto C; Moist LM; Thomson BK; Mann JF; Zimmerman DL
    Nephrol Dial Transplant; 2012 Oct; 27(10):3719-24. PubMed ID: 23114898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
    Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M
    Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is it safe to stop anticoagulants after successful surgery for atrial fibrillation?
    Michael Gray R; Nagendran M; Maruthappu M
    Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):642-8. PubMed ID: 21885540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE; Lake JD
    Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
    [No Abstract]   [Full Text] [Related]  

  • 54. Does long-term warfarin affect the quality of life of older people?
    Das AK; Willcoxson P; Corrado OJ
    Age Ageing; 2005 May; 34(3):312-3. PubMed ID: 15863424
    [No Abstract]   [Full Text] [Related]  

  • 55. Warfarin therapy for atrial fibrillation in general practice--is bleeding risk underestimated?
    Bratland B; Hornnes MB
    Tidsskr Nor Laegeforen; 2014 Jan; 134(2):175-9. PubMed ID: 24477151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.
    Salim I; Al Suwaidi J; Ghadban W; Salam AM
    Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation.
    Lang NN; Connelly DT
    J R Coll Physicians Edinb; 2013; 43(2):151-8. PubMed ID: 23734359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of warfarin in veterans with atrial fibrillation.
    Bravata DM; Rosenbeck K; Kancir S; Brass LM
    BMC Cardiovasc Disord; 2004 Oct; 4(1):18. PubMed ID: 15498102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.